342 related articles for article (PubMed ID: 26372858)
1. Immunogenicity and immunoprotection of porcine circovirus type 2 (PCV2) Cap protein displayed by Lactococcus lactis.
Li PC; Qiao XW; Zheng QS; Hou JB
Vaccine; 2016 Jan; 34(5):696-702. PubMed ID: 26372858
[TBL] [Abstract][Full Text] [Related]
2. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
[TBL] [Abstract][Full Text] [Related]
3. Construction and immunogenicity of recombinant swinepox virus expressing capsid protein of PCV2.
Lin HX; Ma Z; Fan HJ; Lu CP
Vaccine; 2012 Sep; 30(44):6307-13. PubMed ID: 22884664
[TBL] [Abstract][Full Text] [Related]
4. Construction and immunogenicity of recombinant porcine circovirus-like particles displaying somatostatin.
Li W; Wang X; Bai J; Ma T; Li Z; Li Y; Jiang P
Vet Microbiol; 2013 Apr; 163(1-2):23-32. PubMed ID: 23294858
[TBL] [Abstract][Full Text] [Related]
5. A novel vaccine against Porcine circovirus type 2 (PCV2) and Streptococcus equi ssp. zooepidemicus (SEZ) co-infection.
Lin HX; Ma Z; Yang XQ; Fan HJ; Lu CP
Vet Microbiol; 2014 Jun; 171(1-2):198-205. PubMed ID: 24726504
[TBL] [Abstract][Full Text] [Related]
6. Immunity Elicited by an Experimental Vaccine Based on Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein in Piglets.
Zhu S; Zhang C; Wang J; Wei L; Quan R; Yang J; Yan X; Li Z; She R; Hu F; Liu J
PLoS One; 2016; 11(2):e0147432. PubMed ID: 26848967
[TBL] [Abstract][Full Text] [Related]
7. Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-γ in mice.
Wang YP; Liu D; Guo LJ; Tang QH; Wei YW; Wu HL; Liu JB; Li SB; Huang LP; Liu CM
Vaccine; 2013 Jan; 31(5):833-8. PubMed ID: 23219694
[TBL] [Abstract][Full Text] [Related]
8. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions.
Martelli P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Guazzetti S; Caleffi A; Borghetti P
Vet Microbiol; 2011 May; 149(3-4):339-51. PubMed ID: 21216540
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Th1-biased immune efficacy of porcine circovirus type 2 Cap-protein-based subunit vaccine when coadministered with recombinant porcine IL-2 or GM-CSF in mice.
Wang Y; Lu Y; Liu D; Wei Y; Guo L; Wu H; Huang L; Liu J; Liu C
Appl Microbiol Biotechnol; 2015 Feb; 99(3):1155-63. PubMed ID: 25487886
[TBL] [Abstract][Full Text] [Related]
10. Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B.
Hu G; Wang N; Yu W; Wang Z; Zou Y; Zhang Y; Wang A; Deng Z; Yang Y
Vaccine; 2016 Apr; 34(16):1896-903. PubMed ID: 26930366
[TBL] [Abstract][Full Text] [Related]
11. Protective immunity conferred by porcine circovirus 2 ORF2-based DNA vaccine in mice.
Sylla S; Cong YL; Sun YX; Yang GL; Ding XM; Yang ZQ; Zhou YL; Yang M; Wang CF; Ding Z
Microbiol Immunol; 2014 Jul; 58(7):398-408. PubMed ID: 24845706
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice.
Guo XQ; Wang LQ; Qiao H; Yang XW; Yang MF; Chen HY
Microbiol Immunol; 2015 Mar; 59(3):174-80. PubMed ID: 25664504
[TBL] [Abstract][Full Text] [Related]
13. Expression of the capsid protein of porcine circovirus type 2 in Lactococcus lactis for oral vaccination.
Wang K; Huang L; Kong J; Zhang X
J Virol Methods; 2008 Jun; 150(1-2):1-6. PubMed ID: 18406475
[TBL] [Abstract][Full Text] [Related]
14. Immune efficacy of a porcine circovirus type 2 vaccine purified using Gram-positive enhancer matrix surface display technology.
Qiao XW; Yu XM; Li PC; Yu SS; Chen J; Zhang YP; Yang L; Hou LT; Zheng QS; Hou JB
J Appl Microbiol; 2019 Sep; 127(3):658-669. PubMed ID: 31183947
[TBL] [Abstract][Full Text] [Related]
15. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.
Wu PC; Chen TY; Chi JN; Chien MS; Huang C
J Biotechnol; 2016 Feb; 220():78-85. PubMed ID: 26795354
[TBL] [Abstract][Full Text] [Related]
16. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
[TBL] [Abstract][Full Text] [Related]
17. Oral vaccination with the porcine circovirus type 2 (PCV-2) capsid protein expressed by Lactococcus lactis induces a specific immune response against PCV-2 in mice.
Wang L; Zhao D; Sun B; Yu M; Wang Y; Ru Y; Jiang Y; Qiao X; Cui W; Zhou H; Li Y; Xu Y; Tang L
J Appl Microbiol; 2020 Jan; 128(1):74-87. PubMed ID: 31574195
[TBL] [Abstract][Full Text] [Related]
18. Oral vaccination with attenuated Salmonella enterica serovar Typhimurium expressing Cap protein of PCV2 and its immunogenicity in mouse and swine models.
Xu XG; Zhao HN; Zhang Q; Ding L; Li ZC; Li W; Wu HY; Chuang KP; Tong DW; Liu HJ
Vet Microbiol; 2012 Jun; 157(3-4):294-303. PubMed ID: 22326539
[TBL] [Abstract][Full Text] [Related]
19. PCV cap proteins fused with calreticulin expressed into polymers in Escherichia coli with high immunogenicity in mice.
Liu C; Liu Y; Feng H; Zhao B; Chen Y; Huang H; Wang P; Deng R; Zhang G
BMC Vet Res; 2020 Aug; 16(1):313. PubMed ID: 32854700
[TBL] [Abstract][Full Text] [Related]
20. The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts.
Bucarey SA; Noriega J; Reyes P; Tapia C; Sáenz L; Zuñiga A; Tobar JA
Vaccine; 2009 Sep; 27(42):5781-90. PubMed ID: 19664739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]